Allergen-Specific Immunotherapy

  title={Allergen-Specific Immunotherapy},
  author={Anthony J. Frew and Helen E. Smith},
  journal={Allergy Essentials},
2 Citations

Figures and Tables from this paper

Egg Allergy: Diagnosis and Immunotherapy
Advances in molecular techniques allow for the production of safe and standardized recombinant and hypoallergenic egg variants by targeting the IgE-binding epitopes responsible for clinical allergic symptoms, providing a feasible standardized therapeutic approach to target egg allergies safely.


International consensus on allergy immunotherapy.
The efficiency of peptide immunotherapy for respiratory allergy
Data from clinical trials confirmed the efficacy and tolerability of peptide immunotherapy in patients with cat allergy, with a sustained clinical effect after a short course treatment.
Specific immunotherapy in asthma: a comprehensive review
  • G. Passalacqua
  • Medicine
    The Journal of asthma : official journal of the Association for the Care of Asthma
  • 2014
According to the presently available evidence, SLIT and SCIT can be used in asthma associated with rhinitis, provided that asthma is adequately controlled by pharmacotherapy, and a measurable clinical benefit on asthma symptoms can be expected.
Allergen injection immunotherapy for seasonal allergic rhinitis.
This review has shown that specific allergen injection immunotherapy in suitably selected patients with seasonal allergic rhinitis results in a significant reduction in symptom scores and medication use and no long-term consequences from adverse events.
Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial
In conclusion, intralymphatic allergen administration enhanced safety and efficacy of immunotherapy and reduced treatment time from 3 years to 8 weeks.
Long-term clinical and immunological effects of allergen immunotherapy
Findings are largely confined to studies of subcutaneous and sublingual immunotherapy for seasonal pollinosis, and further studies are needed to address potential long-term clinical effects for other seasonal and perennial inhaled allergens in both children and adults.
Epicutaneous Immunotherapy for Aeroallergen and Food Allergy
Historical evidence for the clinical efficacy of epicutaneous allergy immunotherapy (EPIT) has now been strengthened by a number of recent double-blinded placebo-controlled clinical trials performed by independent groups.
Specific allergen immunotherapy for the treatment of atopic eczema.
Overall, the risk of bias was moderate, with high loss to follow up and lack of blinding as the main methodological concern, and the quality of the evidence was low.
Hundred years of allergen immunotherapy
  • A. Frew
  • Medicine
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
  • 2011
Since then, many controlled clinical trials have confirmed the efficacy of SIT, and although some concerns have arisen around safety, SIT remains a valid option for treating allergic disease.